Markus Cornberg, MD, PhD

Clinic for Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany
Hannover, Niedersachsen, Germany

Disclosure(s): AbbVie: Honoraria; Falk: Honoraria; Gilead Sciences, Inc.: Honoraria; GSK: Honoraria; Janssen-Cilag: Honoraria; Merck Sharp & Dohme: Honoraria; Novartis: Honoraria; Roche: Honoraria; Spring Bank Pharmaceuticals: Honoraria; Swedish Orphan Biovitrum: Honoraria

Presentation(s):

• 521 - Efficacy and safety of buleviritide monotherapy for chronic hepatitis D in patients with and without cirrhosis: results from the week 144 interim analysis of a phase 3 randomized study

  Saturday, October 19, 2024
  12:20 PM – 12:25 PM US PT